BLRX

BIOLINE RX LIMITED

BLRX·09071M304·US·ADR·Healthcare - Biotechnology-13D/G

BLRX (BIOLINE RX LIMITED) is held by 11 institutional investors as of Q2 2026. Largest holders: SUSQUEHANNA INTERNATIONAL GROUP, LLP ($95,824), RENAISSANCE TECHNOLOGIES LLC ($48,085), CITADEL ADVISORS LLC ($45,868). Net institutional sentiment: Mixed.

11
Holders
$205,907
Total Value
42% (12)
Consensus
5 buying - 7 selling
13F: Insider & Congress: Updated regularly
BLRX

Smart Money Verdict

View all
Loading verdict
Held by 11 funds

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders none · Activists Aug 14, 2025 · Congress none

ActivistHIHighbridge Capital Management, LLC7.2%Aug 14, 2025

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
30,911$95,8240.0%-13.46%
33
New
15,412$48,0850.0%-13.46%
28
New
14,796$45,8680.0%-13.46%
31
Increased
2,478(+5.3%)$7,6790.0%-81.56%
12
Increased
2,000(+14.3%)$6,2400.0%-92.30%
12
Decreased
500(-72.2%)$1,5500.0%-5.59%
0
Decreased
101(-80.9%)$3150.0%-28.19%
0
Decreased
82(-23.4%)$2560.0%-88.56%
0
Unchanged
26$810.0%-7.85%
0
Unchanged
2$60.0%-11.48%
0
Decreased
1(-99.9%)$30.0%-5.92%
0
Exited
0(-100.0%)$25,2740.0%+11.03%
0
Exited
0(-100.0%)$2300.0%-65.46%
0
Exited
0(-100.0%)$280.0%-17.02%
0
BLRXBLRXBIOLINE RX LIMITED

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used